FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Sandoz Nadolol Tablets Recall

Nadolol Tablets, USP, 40mg, packaged in 1000-count bottle, Rx Only, Manufactured by San…

Sandoz Incorporated · Broomfield, CO

Risk level
Class II
Reported by FDA
Jan 4, 2017
Recall ID
D-0236-2017
Check your lot numberHow we source this data

Summary

Sandoz recalled Nadolol Tablets starting Dec 22, 2016. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0236-2017 on Jan 4, 2017. Reason: Failed dissolution specification: recalled due to an out of specification dissolution result of 40% (Specification: NLT 80%). Status: Terminated.

Why it was recalled

Failed dissolution specification: recalled due to an out of specification dissolution result of 40% (Specification: NLT 80%)

Product description

Nadolol Tablets, USP, 40mg, packaged in 1000-count bottle, Rx Only, Manufactured by Sandoz Inc., Princeton, NJ 08540, NDC 0781-1182-10

Lot numbers, UPCs & expiration codes

Lot GG1539

Where it was sold

MS and OH.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0236-2017
Classification
Class II
Status
Terminated
Recall initiated
Dec 22, 2016
FDA report date
Jan 4, 2017
Quantity
96 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Sandoz Incorporated

Original FDA data

Every field from FDA enforcement report D-0236-2017, exactly as published.

Show all FDA fields
City
Broomfield
State
CO
Status
Terminated
Country
United States
Event ID
76077
Address
2555 W Midway Blvd
Code information
Lot GG1539
Postal code
80020-1632
Report date
Jan 4, 2017
Product type
Drugs
Recall number
D-0236-2017
Classification
Class II
Recalling firm
Sandoz Incorporated
Product quantity
96 bottles
Termination date
Sep 18, 2017
Reason for recall
Failed dissolution specification: recalled due to an out of specification dissolution result of 40% (Specification: NLT 80%)
Voluntary / mandated
Voluntary: Firm initiated
Product description
Nadolol Tablets, USP, 40mg, packaged in 1000-count bottle, Rx Only, Manufactured by Sandoz Inc., Princeton, NJ 08540, NDC 0781-1182-10
Distribution pattern
MS and OH.
Recall initiation date
Dec 22, 2016
Initial firm notification
Letter
Center classification date
Dec 27, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0236-2017, published Jan 4, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls